The case involved Dr. James Elist, a Beverly Hills urologist and Penuma developer, and his company International Medical Devices suing Joshua Cornell over alleged misappropriation of penile implant technology. The Federal Circuit applied California's Uniform Trade Secrets Act, emphasizing that patent disclosures irrevocably place information into the public domain. Oral arguments occurred March 5, 2026, before Judges Dyk, Taranto, and Reyna, with the decision issued approximately April 30, 2026.
The decision reinforces a critical boundary in IP strategy: inventors cannot pursue trade secret protection for information already disclosed through patent applications. For medtech and other patent-heavy industries, the ruling clarifies that public disclosures forfeit any claim to confidentiality, regardless of subsequent efforts to restrict access. Firms should audit whether dual protection strategies—pursuing both patents and trade secrets on the same subject matter—create vulnerabilities in litigation.